Clinical Trial Update: Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF-IGFBP axis in Type 1 diabetes. The study status is COMP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin detemir (insulin detemir)
• NPH insulin (insulin isophane)

Snippet

Sponsor: University of Aarhus | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED